急性肺血管药物扩张试验在评价先天性心脏病合并重度肺动脉高压中的应用进展
被引量:6
摘要
一、先天性心脏病合并重度肺动脉高压继发于左向右分流型先天性心脏病(CHD)的肺动脉高压(PAH)是一种进行性病变,主要表现为肺动脉压力和肺血管阻力的进行性升高,最终导致右心衰竭甚至死亡。这类肺动脉高压按其性质可分为动力性肺动脉高压和梗阻性肺动脉高压,CHD合并重度PAH。
出处
《心肺血管病杂志》
CAS
2011年第4期344-347,共4页
Journal of Cardiovascular and Pulmonary Diseases
参考文献27
-
1张颖,刘双,杨京华.肺动脉高压诊断及分类[J].心肺血管病杂志,2008,27(3):191-192. 被引量:15
-
2Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary ar- terial hypertension. N Engl J Med ,2004,351:1425-1436.
-
3Galie N, Manes A, Branzi A. New insights on pulmonary arteri- alhypertention. Rev Esp Cardio1,2004,57:603-607.
-
4Galie N,Torbicki A,Barst R,et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on di- ognosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Eur Heart J, 2004, 25: 2243-2278.
-
5Simonneau G, Gali6 N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coil Cardiol,2004,43:5S-12.
-
6McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension : a re- port of the American college of cardiology foundation task force on expert consensus documents and the American heart association developed in collaboration with the American college of chest physicians;American Thoracic Society, Inc. ;and the pulmonary hypertension association. J Am Coil Cardiol, 2009, 53 : 1573-1619.
-
7Botha P,Parry G, Dark JH, et al. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure:compari- son of PAHosPAHodiesterase type-3 and -5 inhibition. J HeartLung Transplant ,2009,28:676-682.
-
8Opitz CF and Rubin LJ. Acute vasodilator testing in idiopathic pulmonary arterial hypertension : must we take NO for the answer? Ettr Respir J,2009,33 : 1247-1249.
-
9Buckley MS, Feldman JP. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. PAHarmaeother, 2010,30 : 728 -740.
-
10Lock JE, Einzig S, Bass JL, et al. The pulmonary vascular re- sponse to oxygen and its influence on operative results in children with ventricular septal defect. Pediatr Cardiol, 1982,3:41-46.
二级参考文献26
-
1荆志成,徐希奇.肺动脉高压现代分类和诊断策略[J].中华心血管病杂志,2004,32(12):1160-1162. 被引量:40
-
2王秋芬,廖玉华.欧洲心脏病协会2004年肺动脉高压诊断和治疗指南简介[J].临床心血管病杂志,2005,21(7):385-386. 被引量:57
-
3Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
-
4程显声,郭英华,何建国,荆志成.1996—2005年阜外心血管病医院肺动脉高压住院构成比变化[J].中华心血管病杂志,2007,35(3):251-254. 被引量:34
-
5Dimopoulos K,Giannakoulas G,Wort SJ,et al.Pulmonary arterial hypertension in adults with congenital heart disease:distinct differences from other causes of pulmonary arterial hypertension and management implications.Curr Opin Cardiol,2008,23:545-554.
-
6Gorenflo M,Bettendorf M,Brockmeier K,Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension.Z Kardiol,2000,89:1000-1008.
-
7Wilkinson JL.Haemodynamic calculations in the catheter laboratory.Heart,2001,85:113-120.
-
8Viswanathan S,Kumar RK.Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance.Catheter Cardiovasc Interv,2008,71:665-670.
-
9Galie N,Manes A,Palazzini M,et al.Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger' s syndrome.Drugs,2008,68:1049-1066.
-
10Olschewski H,Simonneau G,Galie N,et al.Inhaled iloprost for severe pulmonary hypertension.N Engl J Med,2002,347:322-329.
共引文献50
-
1马艳莉,冷秋平.西地那非治疗肺动脉高压的临床疗效分析[J].农垦医学,2014,36(3):197-199. 被引量:2
-
2黄艳华,任发成,卢家凯.用伊洛前列素吸入治疗心脏病患者围术期肺动脉高压[J].心肺血管病杂志,2009,28(4):285-287. 被引量:1
-
3夏星,卢家凯,卿恩明.妊娠合并先天性心脏病患者剖宫产麻醉管理45例分析[J].心肺血管病杂志,2009,28(6):392-394. 被引量:20
-
4林多茂,卢家凯,卿恩明.妊娠合并艾森曼格综合征患者麻醉处理1例[J].中华麻醉学杂志,2010,30(2):250-251. 被引量:4
-
5王芳,蒋立虹,顾珏,柳露,牛兆仪,丁云川,李鹏,张富荣,朱明.妊娠合并肺动脉高压49例临床分析[J].中国妇产科临床杂志,2010,11(3):222-223. 被引量:2
-
6李锦娜,陈艳玲,李雪梅.15例完全性肺静脉异位引流矫治病人的术后护理[J].海南医学,2010,21(13):145-147. 被引量:5
-
7王亮,陈鹏.先天性心脏病合并肺动脉高压的药物治疗进展[J].中国医学创新,2010,7(23):192-194. 被引量:16
-
8冯智勇,肖美华,赖新兰.西地那非片在治疗肺动脉高压的应用[J].中国中医药咨讯,2010(30):76-77.
-
9彭月华,高兴才,汤跃卿,杨涛,袁凤林,彭梅仙.西地那非和NO在重度肺动脉高压双向分流先心病围手术期中的应用[J].医药论坛杂志,2010,31(20):155-156. 被引量:1
-
10杨志英,郑浩,周伟利,刘蕾,张亚丽,李旭峰.实时三维超声评价先天性心脏病合并肺动脉高压患者的左心功能及同步性研究[J].心肺血管病杂志,2011,30(1):1-3. 被引量:2
同被引文献39
-
1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:118
-
2Ranu H, Smith K, Nimako K,et al. A retrospective review to evaluate the safety of right heart catheterization via the internal jugular vein in the assessment of pulmonary hypertension[J]. Clin Cardiol, 2010,33 (5) : 303-306.
-
3Barst RJ, Mc Coon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hyperlension [J]. J Am Coll Cardiol,2004,43(12) : 40-47.
-
4Huang H,Zhang P,Wang Z,etal. Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease[J]. Circ J ,2011 ,75(6): 1463-1471.
-
5Adatia I, Kothari SS, Feinstein J A. Pulmonary hypertension associated with congenital heart disease,pulmonary vascular disease: The global perspective[J].Chest,2010,137(Suppl 6) : 52-61.
-
6Barst RJ, Ertel SI,Beghetti M,et al. Pulmonary arterial hypertension: A comparison between children and adults[J]. Eur Respir J, 2011, 37(3):665-677.
-
7Oliveira EC, Ribeiro AL, Amaral CF. Adenosine for vasoreactivity testing in pulmonary hypertension: A head-to-head comparison with inhaled nitric oxide[J]. Respir Med,2010,104(4):606-611.
-
8Badesch DB,Abman SH,Ahearn GS,et al.Medical therapy forpulmonary arterial hypertension:ACCP evidence-based clinicalpractice guidelines.Chest,2004,126:135S-162S.
-
9Limsuwan A,Khosithseth A,Wanichkul A,et al.Aerosolized ilo-prost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart dis-ease.Catheter Cardiovasc Interv,2009,73:98-104.
-
10Jing ZC,Jiang X,Han ZY,et al.Iloprost for pulmonary vasodi-lator testing in idiopathic pulmonary arterial hypertension.EurRespir J,2009,33:1354-1360.
引证文献6
-
1徐善慧,丁青艾,朱智明.右心导管检查评估先天性心脏病合并肺动脉高压16例分析[J].人民军医,2012,55(6):535-536. 被引量:2
-
2李强强,顾虹,张陈,卓玲,刘海菊,郭保静.吸入伊洛前列素在儿童先天性心脏病肺血管扩张试验中的应用[J].心肺血管病杂志,2012,31(4):381-384. 被引量:5
-
3刘洋,沈群山,张刚成,尚小珂,王利军,卢蓉,余莹,陈谦.急性肺血管扩张试验在先天性心脏病相关性肺动脉高压中的意义[J].中国介入心脏病学杂志,2015,23(1):14-17. 被引量:5
-
4林明,朱洪玉,彭晓鹏,蓝少明,柯略森.米力农治疗先天性心脏病合并心力衰竭患儿的临床疗效[J].中国药物经济学,2016,11(5):87-89.
-
5李强强,张陈,刘海菊,张丹,赵万桂,顾虹.吸入伊洛前列素和纯氧在肺动脉高压急性肺血管扩张试验中的对比研究[J].心肺血管病杂志,2017,36(1):18-22. 被引量:3
-
6彭嘉飞,肖瑶,万钧.急性血管反应试验在肺动脉高压评估中的临床应用[J].国际呼吸杂志,2024,44(9):1112-1116.
二级引证文献15
-
1樊扬名,葛建军,林敏.中老年先天性心脏病伴重度肺动脉高压的外科治疗[J].山东医药,2014,54(6):75-77. 被引量:3
-
2刘亚兰,陈燕,李欣.吸入型伊洛前列素治疗新生儿持续肺动脉高压的临床观察[J].中国医院药学杂志,2014,34(6):478-479. 被引量:3
-
3耿洁,许启霞.急性血管反应性试验在肺动脉高压中的研究进展[J].中华结核和呼吸杂志,2015,38(11):857-861.
-
4林明,朱洪玉,彭晓鹏,蓝少明,柯略森.米力农治疗先天性心脏病合并心力衰竭患儿的临床疗效[J].中国药物经济学,2016,11(5):87-89.
-
5张丹,顾虹,张陈,李强强,赵万桂,刘倩.先天性心脏病术后合并肺动脉高压心导管检查及急性肺血管扩张试验分析[J].心肺血管病杂志,2016,35(5):369-372. 被引量:5
-
6曹黎明,金波,王凤鸣,秦玉明,朱善良,陈金龙.儿童动脉导管未闭合并中重度肺动脉高压介入治疗临床分析[J].南京医科大学学报(自然科学版),2016,36(12):1534-1537. 被引量:9
-
7曹黎明,王凤鸣,秦玉明,赵乃琤,杨世伟,朱善良.封堵试验对儿童动脉导管未闭并发重症肺动脉高压性质的判定及介入治疗的意义[J].中国实用儿科杂志,2017,32(2):145-148. 被引量:3
-
8乔利阳.动脉导管未闭对紫绀型先天性心脏病肺血管发育的影响及临床意义[J].临床研究,2017,25(4):6-7.
-
9王春泉.米力农在新生儿肺动脉高压治疗中的效果观察[J].中国卫生标准管理,2019,10(8):70-71. 被引量:2
-
10张志强.药物万他维行急性血管扩张药物试验前后患者的血气指标及心功能指标变化[J].临床医药文献电子杂志,2019,6(73):156-157.
-
1都鹏飞,范晓晨.166例左向右分流型先天性心脏病左心室功能的研究[J].疾病控制杂志,2000,4(3):233-235.
-
2赵慧.40例新生儿先天性心脏病合并肺炎心衰的治疗体会[J].现代医药卫生,2004,20(22):2389-2389.
-
3丁建东,陆凤翔.血管活性肽与肺动脉高压的研究[J].医学综述,2002,8(9):523-525.
-
4安淑华.儿科危重急症急救讲座 第十五讲 呼吸困难(下)[J].中国乡村医药,2013,20(5):38-39.
-
5朱丹,郭彩艳,彭彬,方臻飞.左向右分流型先天性心脏病并肺动脉高压患者血浆中核因子-κB的浓度变化及其与肺动脉高压关系的分析[J].中国循环杂志,2016,31(9):885-887. 被引量:6
-
6王玲玲,邓艾民.依那普利对左向右分流型先天性心脏病心力衰竭神经内分泌的影响[J].中外医学研究,2013,11(29):20-20.
-
7周敬群,曹林生.左向右分流型先天性心脏病肺动脉高压患者血小板活化状态及其意义[J].中国循环杂志,1998,13(3):164-166.
-
8孔霞,于莹,叶晓蕾,高应东,张莉.左向右分流型先天性心脏病患儿血清MMP-2和MMP-9变化[J].中国优生与遗传杂志,2013,21(11):77-78. 被引量:1
-
9郭俊晓,刘志平.转化生长因子β1血清水平与左向右分流型先天性心脏病肺动脉压力的相关性探讨[J].中国医药,2010,5(6):499-500. 被引量:3
-
10文萍,肖秋金,刘蓓,邓晓莉.彩色多普勒超声对左向右分流型先天性心脏病封堵术后疗效的观察[J].南昌大学学报(医学版),2011,51(10):39-42. 被引量:2